THz Rays: A Quantum Leap in Imaging Technology Revolutionby Lilu Anderson 16.06.2024Professor Kenneth O's 15-year effort culminates in 2022 with a THz radiation imaging chip, enhancing portability and offering new application ...
BDAG Soars, TON Aims for $9, DOGE Surges: Crypto Highlightsby John Darbie 16.06.2024Toncoin hits $6.41, up 5.05% in a day, eyeing $9. BlockDAG presale surges over $500k daily, nearing $5 million amid ...
BlockDAG Presale Hits $50.4M; Dev Release 52 Enhances Blockchainby John Darbie 16.06.2024BlockDAG's second keynote highlights global dominance with a presale success of $50.4M, now in Batch 18 at $0.0122. Invest now: ...
Crypto Startup Funding Surpasses $100B Milestoneby John Darbie 16.06.2024Since 2014, crypto startups secured $101.36B in 5,287 rounds; October 2021 led with $7B. U.S. regulatory boost key to $100B ...
AI Advancements Propel TSMC in 3nm Chip Dominanceby Lilu Anderson 16.06.2024TSMC's 3-nanometer chip dominance challenges Samsung; demand surpasses supply with Intel eyeing TSMC for new CPUs, orders booked till 2026.
Is the Bitcoin Bull Market Over? Analysts Weigh Inby John Darbie 15.06.2024Bitcoin hovers at a critical level near $62,800; a dive below $60,000 could plummet it to $48,000. Uncertainty clouds the ...
Horizon Technology Finance Announces Monthly Dividend of $0.11by Mark Eisenberg 15.06.2024Horizon Technology Finance posts $1.32 annual dividend, yielding 11.01%. Ex-dividend date: June 17. EPS forecast: $1.48 for the year. NYSE:CX.
Ethereum ETFs Near Approval in US, Launch Date Uncertainby John Darbie 15.06.2024Ethereum ETFs may debut by July 2, per Eric Balchunas. Unlike BTC, their launch date is still uncertain, contributing to ...
Danone Backs Biotech Open Platform for Precision Fermentationby Lilu Anderson 15.06.2024Precision fermentation is a pioneering biotech process for creating bio-based materials. Danone plans to debut demo-scale production by 2025, expanding ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.